Genaera Corporation (GENR) Presents Additional Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436)
Tweet Send to a Friend
Genaera Corporation (Nasdaq: GENR) announced a presentation by Genaera scientists of preclinical data on trodusquemine (MSI-1436), Genaera's lead drug candidate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
